164 related articles for article (PubMed ID: 35815617)
21. Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.
Charleer S; De Block C; Van Huffel L; Broos B; Fieuws S; Nobels F; Mathieu C; Gillard P
Diabetes Care; 2020 Feb; 43(2):389-397. PubMed ID: 31843948
[TBL] [Abstract][Full Text] [Related]
22. Long-term glucose-lowering effect of intermittently scanned continuous glucose monitoring for type 1 diabetes patients in poor glycaemic control from Region North Denmark: An observational real-world cohort study.
Jensen MH; Cichosz SL; Gustenhoff P; Nikontovic A; Hejlesen O; Vestergaard P
PLoS One; 2022; 17(10):e0274626. PubMed ID: 36240184
[TBL] [Abstract][Full Text] [Related]
23. Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.
Franceschi R; Cauvin V; Stefani L; Berchielli F; Soffiati M; Maines E
Front Endocrinol (Lausanne); 2022; 13():907517. PubMed ID: 35784525
[TBL] [Abstract][Full Text] [Related]
24. Recovery of hypoglycemic confidence using intermittently scanned continuous glucose monitoring among adults with type 1 diabetes with level 3 hypoglycemia: A prospective, single-center, single-arm study.
Takaike H; Miura J; Hoshina S; Takagi S; Takita M; Mochizuki S; Babazono T
Diabetes Res Clin Pract; 2023 Oct; 204():110890. PubMed ID: 37714304
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
[No Abstract] [Full Text] [Related]
26. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial.
Secher AL; Pedersen-Bjergaard U; Svendsen OL; Gade-Rasmussen B; Almdal T; Raimond L; Vistisen D; Nørgaard K
Diabetologia; 2021 Dec; 64(12):2713-2724. PubMed ID: 34495375
[TBL] [Abstract][Full Text] [Related]
27. Use of Flash Glucose Monitoring and Glycemic Control in Patients with Type 2 Diabetes Mellitus Not Treated with an Intensive Insulin Regimen: 1-Year Real-Life Retrospective Cohort Study.
Al Hayek AA; Al Dawish MA
Adv Ther; 2023 Jun; 40(6):2855-2868. PubMed ID: 37133646
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of G5 Mobile continuous glucose monitoring device compared to self-monitoring of blood glucose alone for people with type 1 diabetes from the Canadian societal perspective.
Chaugule S; Graham C
J Med Econ; 2017 Nov; 20(11):1128-1135. PubMed ID: 28745578
[TBL] [Abstract][Full Text] [Related]
29. Effects of intermittently scanned continuous glucose monitoring in adult type 1 diabetes patients with suboptimal glycaemic control: A multi-centre randomized controlled trial.
Yan J; Zhou Y; Zheng X; Zheng M; Lu J; Luo S; Yang D; Deng H; Xu W; Bi Y; Bao W; Weng J
Diabetes Metab Res Rev; 2023 May; 39(4):e3614. PubMed ID: 36670050
[TBL] [Abstract][Full Text] [Related]
30. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
[TBL] [Abstract][Full Text] [Related]
31. Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type II diabetes in France.
Alshannaq H; Pollock RF; Joubert M; Ahmed W; Norman GJ; Lynch PM; Roze S
J Comp Eff Res; 2024 Mar; 13(3):e230174. PubMed ID: 38294332
[No Abstract] [Full Text] [Related]
32. Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia.
Charleer S; De Block C; Bolsens N; Van Huffel L; Nobels F; Mathieu C; Gillard P
Diabetes Technol Ther; 2023 Apr; 25(4):231-241. PubMed ID: 36648249
[No Abstract] [Full Text] [Related]
33. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial.
Rose S; Styles SE; Wiltshire EJ; Stanley J; Galland BC; de Bock MI; Tomlinson PA; Rayns JA; MacKenzie KE; Wheeler BJ
Diabet Med; 2022 May; 39(5):e14756. PubMed ID: 34862661
[TBL] [Abstract][Full Text] [Related]
34. Impact of intermittently scanned continuous glucose monitoring on quality of life and glycaemic control in persons with type 1 diabetes: A 12-month follow-up study in real life.
Duarte DB; Fonseca L; Santos T; Silva VB; Puga FM; Saraiva M; Silva IL; Teixeira S; Vilaverde J; Cardoso MH
Diabetes Metab Syndr; 2022 Jun; 16(6):102509. PubMed ID: 35598543
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study.
Deshmukh H; Adeleke K; Wilmot EG; Folwell A; Barnes D; Walker N; Saunders S; Ssemmondo E; Walton C; Patmore J; Ryder REJ; Sathyapalan T
Diabetes Obes Metab; 2024 Apr; 26(4):1333-1339. PubMed ID: 38164758
[TBL] [Abstract][Full Text] [Related]
36. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
[No Abstract] [Full Text] [Related]
37. Effects of 12-Week Freestyle Libre 2.0 in Children with Type 1 Diabetes and Elevated HbA1c: A Multicenter Randomized Controlled Trial.
Jefferies CA; Boucsein A; Styles SE; Chamberlain B; Michaels VR; Crockett HR; De Lange M; Lala A; Cunningham V; Wiltshire EJ; Serlachius AS; Wheeler BJ
Diabetes Technol Ther; 2023 Dec; 25(12):827-835. PubMed ID: 37782139
[No Abstract] [Full Text] [Related]
38. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4).
Fokkert M; van Dijk P; Edens M; Barents E; Mollema J; Slingerland R; Gans R; Bilo H
BMJ Open Diabetes Res Care; 2019; 7(1):e000809. PubMed ID: 31875133
[TBL] [Abstract][Full Text] [Related]
39. Long-term health economic evaluation of intermittently scanned glucose monitoring compared with self-monitoring blood glucose in a real-world setting in Finnish adult individuals with type 1 diabetes.
Mustonen J; Rautiainen PA; Lamidi ML; Lavikainen P; Martikainen J; Laatikainen T
Diabetes Technol Ther; 2024 Jun; ():. PubMed ID: 38842899
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
